Current Results and Future Research Priorities in Late Effects after Hematopoietic Stem Cell Transplantation for Children with Sickle Cell Disease and Thalassemia: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric Hematopoietic Stem Cell Transplantation
Shalini Shenoy(Washington University in St. Louis), Mark C. Walters(UCSF Benioff Children's Hospital), K. Scott Baker(Malaria Consortium), Javid Gaziev(Policlinico Tor Vergata), Allison A. King(The University of Texas Health Science Center at Houston), Monica Bhatia(Columbia University Irving Medical Center), Staci D. Arnold(Children's Healthcare of Atlanta), Emanuele Angelucci(Ospedale Policlinico San Martino), Dorine Bresters(Willem-Alexander Kinderziekenhuis), Angela R. Smith(University of Minnesota Children's Hospital), Andrew C. Dietz(Dana-Farber/Boston Children's Cancer and Blood Disorders Center), Josu de la Fuente(Imperial College Healthcare NHS Trust), Christine Duncan(Dana-Farber/Boston Children's Cancer and Blood Disorders Center), Michael A. Pulsipher(Primary Children's Hospital)
Cited by 85
Related Papers
Hematopoietic Stem-Cell Gene Therapy for Cerebral Adrenoleukodystrophy
|New England Journal of Medicine|2017|592
Hyponatremia among Runners in the Boston Marathon
|New England Journal of Medicine|2005|553
Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study
|The Lancet Haematology|2020|553
Long-Term Outcomes Among Adult Survivors of Childhood Central Nervous System Malignancies in the Childhood Cancer Survivor Study
|JNCI Journal of the National Cancer Institute|2009|530